UCFA
AGN

United Capital Financial Advisors’s Allergan Inc AGN Stock Holding History

United Capital Financial Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-14,692
Closed -$3.12M – 1310
2014
Q4 		$3.12M Buy
14,692
+2,865
+24% +$570K 0.05% 367
2014
Q3 		$2.11M Sell
11,827
-57
-0.5% -$9.47K 0.04% 428
2014
Q2 		$2.01M Sell
11,884
-1,748
-13% -$272K 0.04% 415
2014
Q1 		$1.69M Buy
+13,632
New +$1.66M 0.04% 382
2013
Q4 		– Sell
-64,914
Closed -$5.87M – 813
2013
Q3 		$5.87M Buy
64,914
+417
+0.6% +$37.4K 0.19% 118
2013
Q2 		$5.43M Buy
+64,497
New +$6.69M 0.14% 172

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

United Capital Financial Advisors's AGN Position: Q1 2015 in Review

United Capital Financial Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 14,692 shares — an estimated $3.12M sold.

United Capital Financial Advisors first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $5.87M in Q3 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • United Capital Financial Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • United Capital Financial Advisors sold 14,692 Allergan Inc shares in Q1 2015, an estimated $3.12M.
  • United Capital Financial Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • United Capital Financial Advisors's Allergan Inc position peaked at $5.87M in Q3 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on United Capital Financial Advisors's 13F filing for Q1 2015, filed 14 May 2015.